The aim of the present work is two-fold: to develop numerical procedures for a priori determining whether a given cell population, having a distributed cell-cycle duration, will grow or decay when subjected to prescribed chemotherapy; to evaluate the cumulative error in the long-term predictions for such populations. We show that cell population dynamics under drug treatment can be modelled by iterative application of a compact operator on the initial cell age-distribution. We further show that this model can be approximated by iterative application of matrices on some finite dimensional vector, containing initial conditions. Moreover, we develop a method for estimating growth-rate of the cell population and show that in fully periodic treatments the estimated error does not grow as time tends to infinity. From the biomedical view point this means that only fully periodic (strictly periodic) schedules can be considered for successfully predicting the long-term effect of chemotherapy. Thus, cyclic drug treatment is shown to be advantageous, not only in increasing selectivity of chemotherapy, as has been previously demonstrated, but also in increasing long-term predictability of specific treatment schedules.
Introduction
Why have we made so little progress in the war against cancer? While there have been substantial achievements in the last thirty years, the USA annual death toll has risen over 73% over this period. One of the major reasons for that is that investigators rely on models that are consistently bad in predicting treatment success (Fortune Magazine, March, 2004) .
Although the above argument refers to the poor predictability of animal models for human cancer, mathematical models of cancer suffer from a similar draw-back, in that they seldom are both realistic enough and predictive enough to have longrange clinical implications.
Numerous mathematical models of cancer, which take into account different levels of tumor organization have been developed, while multiscale modelling of multicellular systems has been critically analyzed by Bellomo et al 11 . The present work is related to a simplified approach in which tumor and host organism are considered as groups of cells whose growth dynamics under cell-cycle phase-specific drug treatment is studied. A mathematical theory suggests the existence of a resonance phenomenon, in which intermittent delivery of cell-cycle phase-specific drugs, at intervals equivalent to the mean cell-cycle time of host cells, can minimize harmful toxicity without compromising therapeutic effects on target cells (The Z-Method) 1,2,3 . Subsequently, explicit general formulae have been derived for the growth or decay of cell populations that are subjected to repeated pulse delivery of cell-cycle phase-specific drugs 10, 12 , and an algorithm has been developed for calculating the required length of treatment for this protocol 7 . The existence of this resonance phenomenon has been further demonstrated for a general class of chemotherapy functions, thus supporting the underlying theory 19, 24, 25, 29 . The predictions of the Z-method have been verified in experiments in mice bearing lymphoma, treated by repeated pulse delivery of the anti-cancer drug, Ara-C, and by the anti-viral drug AZT. In these experiments it has been shown that when the rhythm of drug delivery roughly coincides with the characteristic bone-marrow cell-cycle time, animals survive and myelotoxicity is significantly reduced. The optimal spacing of repeated treatments was determined by measurements of the kinetics of cell movement through different cell-cycle phases. These experiments showed that it is feasible to control host toxicity by rational drug scheduling, based on the Zmethod 4,5,9,27 . Realistic models of cell population dynamics take into account distributions of cell-cycle length in the population. For some specific distributions of cell-cycleduration (normal 3 or some other 3,12,29 described below) it was shown both analytically and numerically 3, 12, 29 that resonance in cell population growth takes place when the drug is administered regularly every τ , where τ equals the mean cell-cycleduration or is its integer or a fractional multiple. It is shown that the resonance is sharper for smaller variance in the distribution of cell-cycle duration 3 . However, the applicability to the clinic of cell population models with generally distributed cell-cycle has yet to be shown.
The main aim of the present work is to develop numerical procedures for a priori determining whether a given cell population, having a distributed cell-cycle duration, will grow or decay when subjected to prescribed chemotherapy. We will show that cell population dynamics under a drug treatment can be modelled by iterative applications of compact operator on the initial cell age-distribution. We further show that the model can be approximated by iterative applications of matrices on some finite dimensional vector, containing initial conditions. Moreover, we will develop a method for growth-rate estimation and will show that under fully periodic treatments the estimation error does not grow as time tends to infinity. In addition, the problem of inexact initial data will also be considered and the criteria for determining whether or not this inexactness is crucial for cell population growth estimation will be developed.
Continuous Model
In this section the differential equation, describing cell age distribution n(a, t), is integrated, and as a result the recursive formula for r(t) = n(0, t) is obtained. Here a is a cell age and t is a time. It will be shown that the behavior of r(t) determines the behavior of N (t), that is, the number of cells at time t, as t tends to infinity.
The model equations, describing cell age distribution are n t (a, t) + n a (a, t) = −(β(a) + η(a, t))n(a, t), a > 0, t ∈ R, (2.1)
where n a and n t denote partial derivatives ∂n/∂a and ∂n/∂t, respectively 12,20,26 . The age-specific division rate of cells is β(a), the age-specific mortality rate (due to natural causes or to a treatment) of cells is η(a, t), and the initial age distribution of cells is n 0 (a). The function β(a) satisfies β(a) = f (a)/α(a), where a2 a1 f (a)da is the probability that a cell divides between ages a 1 and a 2 and α(a) = ∞ a f ( a)d a (the function α(a) gives the fraction of cells undivided by age a). In our case the support of β (the set of all of points on which β has nonzero values) is a subset of
In this particular model we assume that the division and mortality rates of the population are independent of the population density. It should be noted that in general, the division rate of cell population may depend on the total cell number. This can be so in noncancerous cells populations, where β and η depend also on the total number of the cells, N (t) = τm 0 n(a, t)da. In such cases, being out of the scope of the present article, β(N, a) is a decreasing and η(N, a, t) is an increasing functions of N (negative feedback regulation of overall cells number).
Our approach to solving the system (2.1-2.3) is close to that of O.Diekmann et al 13, 14 , except that we use a less general basic system of equations in order to achieve more explicit results. Both Diekman et al, and G.F. Webb 19, 28, 29 have analyzed the behavior and stability of the system (2.1-2.3), while we focus our study on the prediction capacity of the models, where tractability is traded-off by increased realism and, hence, population growth is numerically estimated. In the works of G.F.Webb it is assumed that cells can divide as of the zeroth age. In reality, this is not the case, and therefore, we replace this assumption by minimal division age being τ b > 0. This latter assumption enables recursive evaluation of n(a, t) as t increases. As a consequence, when n(a, t) is given for any positive a and for any negative t and is continuous and integrable, it is possible to calculate n(a, t) for any positive time and the existence and uniqueness of solution follows automatically (see (2.9), (2.11), (2.15)). When τ b = 0, the solution for n(a, t) is written as functional implicit equation and the proof of uniqueness and existence is difficult to obtain 19, 28, 29 .
Let us find general solutions of (2.1-2.3) in the form n(a, t) = m(a, t − a) (it is clear that η = t − a is a characteristic curve of the equation (2.1)). Let us denote η(a, t) = η(a, t + a) The equations (2.1-2.3) take the following form:
It is easy to see that
where r(ζ) is any C 1 (continuously differentiable) function, which in each specific case is determined by given boundary conditions. Thus n(a, t) = r(t − a)F (a)Θ(a, t), (2.9)
where Θ(a, t) describes treatment activity. For very aggressive treatment Θ(a, t) tends to 0 and in the absence of the drug Θ(a, t) = 1. The boundary condition (2.3) looks as
It follows from (2.9) that n(0, t) = r(t) (2.12) thus r(t) is always finite from its biological definition. Thus the set of all admissible functions n 0 (a) must be such that lim
Θ(a,0)F (a) exists, making (2.11) legitimate. Boundary condition (2.2) reads as
From (2.13) and (2.14) follows that
In Appendix A.1 we prove that in the generic case, the total cell number N (t) has similar growth rate (in the sense that will be explained later) as r(t) for t big enough. Thus, in the case that lim t→∞ r(t) exists, the population is eliminated if and only if lim t→∞ r(t) < 1 and it increases exponentially if and only if lim t→∞ r(t) > 1. In the following sections we consider the behavior of r(t), as t tends to infinity, and explore numerical methods for its estimation.
Iterative Solution For r(t)
The solution for r(t) can be obtained recursively from r(t) for negative t using (2.15) as follows. Let
where
+ 1, is either finite or infinite. In this paper we consider the finite case, i.e. τ m < ∞. (3.2) defines recursively {r n (t)} ∞ n=1 , provided that r −M (t), ..., r 0 (t) are known.
Operator Formalism
In this section we consider the stability of the growth-rate of the solution r(t) as t tends to infinity as well as the accuracy of the proposed finite dimensional approximations. The following definitions are very important for the further discussion:
M +1 with a following inner product:
It is clear that H with this inner product constitutes Hilbert space. Now we define partial order relation on H, as follows:
For any x in H we say that x is (strictly) positive if every its component is a (strictly) positive function and denote this by x ≥ 0 (x > 0). For any x, y in H we say that x ≥ y (x > y) if x − y ≥ 0 (x − y > 0). Definition 3. Let H + and H ++ be subsets of H, containing all M + 1-dimensional vectors, whose elements are nonnegative and strictly positive functions, respectively. We call operator K on H positive (strictly positive) if
, and we write K ≥ 0 (T > 0) to denote that K is positive (strictly positive). For any two operators S 1 and S 2 on H we say that
Let us denote
. . .
Thus equation (3.2) can be re-written in the following form: 2) and the initial conditions are given by v 0 . Clearly {T n } ∞ n=1 is a sequence of compact operators from H to H. In the case of cyclic treatment there is a minimalp > 0, such that Θ(a, t) = Θ(a, t +p) for any a > 0 and any t > t 0 . There are two possibilities: 1)p/τ b is rational; 2)p/τ b is irrational; In the second case we can take τ
Thus in any case we suppose, without loss of generality, thatp/τ b is rational, i.e.p/τ b = P/P ′ , where P and P ′ are natural numbers and P/P ′ is irreducible. Thus Θ(a, t) = Θ(a, t + P τ b ) for any a > 0, t > t 0 and P is the minimal natural number with this property. From this it easily follows that {T n } ∞ n=1 is a periodic sequence of operators with the minimal positive period P . Then T = T 1 · T 2 · ... · T P is a compact operator on H and for every initial vector v 0 ∈ H we have P sequences
and obtain sequence of vectors of functions r n (t), r n+1 (t), ..., r n+M (t) ∞ n=1 in the following way:
for any natural n, represented as n = m P + i, 0 ≤ i < P . This means that behavior of r(t) in infinity is determined by {T m } ∞ m=1 . The following theorem gives an estimation of the treated cell population growth through spectral radius of the operator T :
is true always and
is true in generic case, where in complete analogy to (3.1),
The proof of Theorem 1 is given in A.1. From this theorem it follows immediately that the value of the spectral radius ρ(T ) fully characterizes population growth or decay: The population grows exponentially if ρ(T ) > 1 and decays if ρ(T ) < 1. These rates are bounded by ρ(T ) and tend to it for almost all initial conditions (which are represented by nonnegative functions). In the following section of this article the problem of effective approximation of ρ(T ) is discussed.
Numerical Approximation For r(t) And Applications
We propose a finite dimensional approximation to {r n } 
,
In both cases we approximate E j,n (ν, s) with step functions, bounding it from above (superscript "u") or from below (superscript "l"). It follows recursively that {r 
Thus all eigenvectors of T l and T u are contained in H N . Keeping in mind isometry of H with C N (M +1) , we can treat T l and T u as finite dimensional matrices in order to find their spectral radiuses. Different effective algorithms has been developed for this purpose 23 . The following theorem, whose proof is given in A.2, shows how ρ(T ) can be estimated using ρ(T l ) and ρ(T u ):
3)
The proof of Theorem 2 is provided in Appendix A.2. From Theorem 1 follows a property, associated with fully periodic treatments: when subjected to fully periodic drug treatments, the behavior of a cell population at large t is determined by the spectral radius of some operator T . This means that the inexactness in the evaluation of cell population dynamics is determined by the inexactness of the population growth-rate estimation at any time. Thus, the error in the initial data will lead to a bounded error in the evaluation of the population growth-rate for large t. Theorem 5.2 enables to evaluate this error, as follows: we assume that the distribution function f and the chemotherapy determining function, Θ(a, t), are Riemann integrable. Thus, for any ε > 0 it is possible to find a natural number N , determining the equal partition of [0, τ b ], as discussed before, such that
, from which will follows that ρ(T ) differs from ρ(T u ) and ρ(T l ) by less than ε. One of the problems any predictive mathematical model has to cope with is the inexactness of the biological data. In the present model, if we know f up to some accuracy, the following question arises: given a cyclic drug treatment, is the inexactness in the biological input data crucial for our prediction ability of population growth or extinction?
Let
Let 1 T and 2 T be the respective operators on H. Then by Proposition A.2.1, presented in Appendix, it follows that ρ( 1 T ) ≤ ρ(T ) ≤ ρ( 2 T ). Given any ε > 0, we can evaluate ρ( 1 T ) and ρ( 2 T ) with accuracy less than ε. In the generic case ρ(T ) = 1. Thus we can assume that for sufficiently small ε the set (ρ(T ) − ε, ρ(T ) + ε) is either from the left or from the right of 1, from which follows that both ρ( 1 T ) and ρ( 2 T ) are larger or less than 1, or ρ( 1 T ) < 1 < ρ( 2 T ). In the first case the population increases, in the second it decreases and in the third case the provided data for f are not sufficient.
Discussion
In present work we have analyzed age-structured model for cancer cells treated by chemotherapy. The model is presented in terms of PDE with boundary conditions for population density function. Under a reasonable assumption of existence of minimal and maximal possible values of cell-cycle length, we obtained an iterative solution of the equation. We showed that under a strictly cyclic treatment the asymptotic behavior of the cell number N (t) is similar to that of r(t), i.e. the density of cells of age 0 at time t. The iterative equation for r(t) was presented using operator formalism on Banach space of vectors of real functions. The solution is given by iterative application of the compact operator T on the vector of initial conditions. Theorem 1 shows that the asymptotic behavior of population size is determined by the spectral radius ρ(T ). Thus, we turn to the problem of evaluation of spectral radius of compact operator. To this end, we propose finite-dimensional approximation of N (t) and r(t) with step functions, bounding them from above and from below. This approximation is based on partitioning the time axis into intervals of length τ b /N , and on considering the space of functions which are constant on each of these intervals. We have shown that this approximation induces approximation of T by operators T u and T l bounding it from above and below. These operators act on N -dimensional space of piecewise constant functions that approximate the original real-valued functions. We show that by choosing finite-dimensional approximations, close enough to T , we can evaluate ρ(T ) with arbitrarily small error. The precision of this approximation depends on N . We propose the following algorithm: given the equation, approximate ρ(T ) to the desired precision, so that the interval [ρ(T l ), ρ(T u )] lies entirely below or above 1 (this is the generic case). Then ρ(T ) lies within this interval, and the asymptotic behavior of N (t) is known. Note, that in the case ρ(T ) = 1 the algorithm does not give a solution to the problem and, indeed, in this case the asymptotic behavior of N (t) is unknown -it can be bounded or grow subexponentially (e.g. in a polynomial fashion). Since this case is not generic, its consideration has little practical importance.
We also discuss the problem of inexactness of the biological measurements, i.e. when the parameters of the equation are given up to some error. In this case we assume that T 1 ≤ T ≤ T 2 (in operator sense). We can evaluate ρ(T ) as lying within the interval [ρ(T 1 ), ρ(T 2 )], or in the finite-dimensional approximation, as lying within
If no approximation can locate this interval strictly below or above 1, we can state that the biological data are not exact enough for inferring the asymptotic behavior of N (t). We also stress that a strictly periodic treatment only allows such estimations as above, since in this case the evaluation error of population growth rate does not accumulate due to the periodicity of the solution. Such a predictability is the advantage of periodic regimens over non-periodic ones.
Perspectives
A number of generalizations can be added to the model. First and foremost, cell populations whose growth-rate depends on population density need to be considered. In addition, populations can consist of several subpopulations that differ in cell age distribution functions, so that selection during the treatment can take place. Drug diffusion and spatial heterogeneity can also be taken into account. In practice, the treatment can not be ideally cyclic, so stochastic deviations in drug application can be introduced into the model. The putative effect on cell population dynamics of cell-cycle arrest, caused by some phase-specific drugs, should also be explored.
In the Appendix we present proofs of Theorem 1 and of Theorem 2. These proofs employ results on positive and compact operators. For a more profound survey of this subject see references 15, 16, 17 .
Appendix A.
A.1. Proof Of Theorem 1.
In order to prove Theorem 1 several important results from operator theory are presented. Let us bear in mind the following elementary fact in operator theory: If X is a Banach space, v ∈ X and A is a bounded operator on X, then
The following proposition with its proof can be found in 22 .
Proposition A.1.1. For any positive compact operator K on H, the spectral radius ρ(K) is an eigenvalue of K with at least one eigenfunction x ≥ 0.
Proposition A.1.2. For any positive compact operator K on H and for any v ∈ H, lim n→∞ ||K n v|| 1 n ≤ ρ(K), and for almost every v ∈ H + , lim
Proof of Proposition A.1.2. The first part of this proposition can be obtained trivially from (A.1) and (A.2) as follows:
In order to prove the second part, it is sufficient to prove that the set v lim
which is open and dense in H + . Let H +++ be a set of strictly positive functions in H + , such that their infimum is also positive. It is clear that H +++ is open and dense in H + . Let e T be a unit vector in H + , which is an eigenvector of ρ(T ) (from Proposition A.1.1 we know that e T exists). Let W be a subspace of H +++ of all the vectors having nonzero product with e T , such that for each w ∈ W there exists a small δ w > 0, such that w − δ w e T ∈ H +++ . It is clear that W contains open and dense set in H +++ and thus in H + . Then for any w ∈ W
As n tends to infinity the last inequality in (A.3) looks as lim
This completes the proof of Proposition A.1.2.
Proof of Theorem 1. By definition of total cell number at time t, N (t) and in complete analogy to (3.2), (A.4) we get:
It is clear that 0 ≤Ẽ j,n (ν, s) ≤ 1 for any natural j, n, and s, ν
because of addition of nonnegative term
Here M 1 is such a constant, for which ||α|| 1 ≤ M 1 ||α|| 2 for any vector α ∈ C M +1 (M 1 exists because every two norms on finite dimensional Banach spaces are equivalent). Cauchy-Schwartz inequality has been used in (A.6). The last inequality in A.6 is based on the fact that for any real numbers a 1 , . . . , a k the following inequality is always takes place:
It should be noted that in this article the sign of norm of any object relates to space, where the object is situated, for example in (A.6) ||r i || means norm of r i in L 
Bear in mind the notations of Proposition A.1.2: e T is a unit vector in H + which is an eigenvector of ρ(T ), let W be a subspace of H +++ of all the vectors of H having nonzero product with e T , such that for each w ∈ W there exists a small δ w > 0, such that w − δ w e T ∈ H +++ . It has been shown that W is open and dense in H + . Let us denote by
and N * (t) are r(t) and N (t) respectively for initial conditions of r(t), determined by e T (i.e. r 1 − j = (e T ) M +1−j , j = 1, ..., M + 1.
Thus in generic case, taking v 0 ∈ W , determining initial conditions for r(t), as has been mentioned before, we have 
is a periodic sequence with period P of functions. Thus, without loss of generality, we can assume that there is l 0 ∈ {0, 1, · · · , P − 1}, such thatT n k θ jn k −1 e T , θ jn k e T ≡T l0 θ j l 0 e T , θ j l 0 −1 e T . From this, from (A.13) and from the fact that [0, τ b ] is a compact set, it follows that there is s * ∈ [0, τ b ], which is a density point ofT l0 θ j l 0 e T , θ j l 0 −1 e T . It is obvious
some time t * then N * (t) ≡ 0 and r * (t) ≡ 0 for any t > t * , because N * (t) is a total number of cells at time t and r(t) = n(0, t), density of cells at time t and at zeroth age. Thus r * n (s) ≡ 0 for any n > l 0 τ b and any s ∈ [0, τ b ]. From this it follows that T n e T ≡ 0 for all n > l 0 + M + 1, and this is contradiction to the fact that e M is eigenvector of T relative to ρ(T ), which is positive. This proves Proposition A.1.3.
We proceed with the proof of Theorem 1 as follows: from Proposition A.1.3 and from (A.12) it follows immediately that
in the generic case. From (A.7) and (A.14) follows that in the generic case the following limit exists for every s ∈ [0, τ b ]:
A.2. Proof Of Theorem 2
From the definition of T , T l and T u , it is clear that they are positive operators. The following proposition is a classical result 16 in theory of positive operators:
Proposition A.2.1. Given S 1 , S 2 being any bounded positive operators on H, such that S 1 ≥ S 2 , their spectral radii satisfy similar inequality:
It has a practical significance: it states that the order is preserved by the map, which is defined on the set of all bounded positive operators on H, and assigns to any such operator its spectral radius. It is clear that (5.2) in Theorem 2 follows immediately from Proposition A.2.1.
In order to prove (5.3) in Theorem 2 we use the following proposition:
Proposition A.2.2. Assume that S 1 and S 2 are operators on C N , such that ||S 1 − S 2 || < ε in operator norm, then
(A.17)
In order to prove this proposition let us prove the following two lemmas:
Lemma A.2.3. Assume that A 1 and A 2 are operators on C N , such that ||A 1 − A 2 || < ε in operator norm, and A 1 has N different eigenvalues {λ 1 , ..., λ n }, then
Proof of lemma A.2.3. It is possible to choose an orthonormal basis {e 1 , ..., e N } of C N as a set of eigenvectors of A 1 , {λ 1 , ..., λ n } respectively. Assume that λ is an eigenvalue of A 2 , such that |λ| = ρ(A 2 ). Then
for some vector w ∈ C N , ||w|| = 1. Thus 20) from which follows immediately that
where w j =< w, e j >, j = 1, ..., N . Now assume that |λ j − λ| > ε for any j ∈ {1, ..., N }. Then
which is contradiction to (A.21). Thus there exists j 0 ∈ 1, ..., N such that
from which we get immediately (A.18).
Lemma A.2.4. For every ε > 0 and every operator S on N -dimensional C N there exists S ε , an operator on C N , such that ||S ε − S|| < ε, the distance between spectra of S and S ε is less than ε (i.e. for each eigenvalue of S exists eigenvalue of S ε such that distance between them is less than ε, and vice versa), S ε | span{e1,...,eN } is an isomorphism, S ε has N different eigenvalues. For any given isomorphism U on C N the transformation C → U −1 C U is continuous (on the space of all matrices on C N ). Thus, we can easily choose δ ε < ε such that ||U −1 B δε U − S|| ≤ ε. Let us define S ε on H as U −1 B δε U . Clearly S ε satisfies all the demands of the lemma. Now we proceed to prove Proposition A.2.2, as follows hereafter. If both S 1 and S 2 have distinct eigenvalues, then we apply Lemma A.2.3 twice, interchanging the roles of S 1 and S 2 and obtain (A.17). Otherwise, given any δ > 0, using Lemma A.2.4 we find S which is true for any δ > 0. In the limit δ → 0 (A.28) becomes (A.17).
